Tosha Brandon
Family · Amarillo, TXNPI 1114572666
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 88 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 32 manufacturers, the largest accounting for just 9.0% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $1,167 and has fallen 87.5% since, to $146 in 2025.
Across 88 payments — averaging $19.18 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$152
- GSK$125
- Genentech USA, Inc.$125
- Amgen$123
- Regeneron Healthcare Solutions, Inc.$90
- Gilead$89
- plus $984 from 26 others
What the payments were for
- Food & beverage$1,61396%
- Education$754%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 11 | $152 |
| GSK | 4 | $125 |
| Genentech USA, Inc. | 6 | $125 |
| Amgen | 6 | $123 |
| Regeneron Healthcare Solutions, Inc. | 4 | $90 |
| Gilead | 6 | $89 |
| Sanofi | 4 | $84 |
| Sobi, Inc | 1 | $75 |
| Pharmacosmos Therapeutics Inc. | 2 | $74 |
| AstraZeneca | 4 | $71 |
| Beigene USA, Inc. | 4 | $59 |
| Organon | 3 | $54 |
| Lilly USA, LLC | 2 | $48 |
| Bayer | 3 | $47 |
| Incyte Corporation | 3 | $47 |
| Seagen Inc. | 3 | $46 |
| Johnson & Johnson | 3 | $45 |
| Merck | 2 | $42 |
| Pharmacyclics LLC, An Abbvie Company | 2 | $42 |
| AbbVie | 2 | $37 |
| Daiichi Sankyo Inc. | 2 | $35 |
| AVEO Pharmaceuticals, Inc. | 1 | $25 |
| Tersera Therapeutics LLC | 1 | $21 |
| Epizyme, Inc. | 1 | $19 |
| Rigel Pharmaceuticals, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Agios Pharmaceuticals, Inc. | 1 | $16 |
| Acceleron Pharma, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Blueprint Medicines Corporation | 1 | $14 |
| Myriad Genetic Laboratories, Inc. | 1 | $11 |
| Mayne Pharma Commercial LLC | 1 | $7 |
How this compares
$1,688 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Other family in Amarillo
- Kyla BeedyAmarillo$54K
- Tiffany RandleAmarillo$50K
- Cory PickettAmarillo$34K
- David WeirDallas$959K
- Robin BeachHouston$428K
- April LopezMcAllen$417K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
- Jill CampbellShenandoah$182K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.